At Courage Against Cancer (CAC), we believe a meaningful role in colorectal cancer care? One important piece of context is how fenbendazole compares to mebendazole — its better-studied cousin.
At Courage Against Cancer (CAC), we believe a meaningful role in colorectal cancer care? One important piece of context is how fenbendazole compares to mebendazole — its better-studied cousin.
At Courage Against Cancer (CAC), we believe patients deserve evidence-based answers to the pillar article primary question: Can repurposed antiparasitic drugs play a meaningful role in colorectal cancer research? Fenbendazole has generated significant public attention, but it isn’t the only benz…
The article discusses an Expression of Concern issued by Anticancer Research regarding the Hulscher et al. study on ivermectin and mebendazole. It highlights data verifiability issues, the authors’ conflicts of interest tied to The Wellness Company, and how this study differs from credible cancer research, ultimately urging caution for patients evaluating such claims.
Courage Against Cancer emphasizes the importance of personalized cancer treatment plans, tailored based on cancer type, stage, and individual patient factors. This guide details various treatment modalities, including chemotherapy, radiation, immunotherapy, hormone therapy, and stem cell transplants, while encouraging patients to engage with their healthcare teams for informed decisions.
The article from Courage Against Cancer emphasizes the importance of critically evaluating cancer treatment claims, particularly viral studies like the 2026 Hulscher et al. ivermectin-mebendazole paper. It provides a structured framework for assessing study validity, distinguishing between preclinical and clinical evidence, and understanding potential conflicts of interest to make informed treatment decisions.